Luliact Cream contains Luliconazole 1% w/w, a topical antifungal agent indicated for the treatment of superficial fungal infections of the skin such as dermatophytosis, tinea corporis, tinea cruris, and tinea pedis. Luliconazole belongs to the azole class of antifungals and exerts its effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. The cream formulation ensures effective local delivery and penetration into the stratum corneum, providing targeted antifungal activity with minimal systemic absorption. Luliact Cream is typically applied once daily to the affected area and surrounding skin after cleansing and drying, continuing treatment for the duration prescribed by a healthcare professional, usually ranging from 1 to 2 weeks depending on the infection type and severity. Common adverse effects are generally mild and may include local irritation, burning sensation, or erythema at the application site. Luliact Cream is contraindicated in patients with known hypersensitivity to luliconazole or any cream excipients. It is advised to avoid contact with eyes and mucous membranes. Use during pregnancy and lactation should be under medical supervision. This product offers an effective and convenient option for managing superficial fungal infections with a favorable safety profile.